Introduction:
Polycystic ovary syndrome is the most frequently encountered endocrinopathy in women of reproductive age. It is associated with significant morbidity in terms of both reproductive and non-reproductive events 1 .
The condition was first described in 1935 by Stein and Leventhal as a syndrome manifested by amenorrhoea, hirsutism and obesity associated with enlarged polycystic ovary 2 .
According to Rotterdam Criteria a refined definition of PCOS was the presence of two out of the following three criteria.
1. Oligomenorrhoea/or anovulation.
Hyperandrogenism (clinical and/or biochemical).
3. Polycystic ovaries with the exclusion of other aetiologies 3 .
Polycystic ovaries are seen at ultrasound in 20-25% women of reproductive age while PCOS occurs at least 4-6% of the population. The prevalence of polycystic ovary syndrome seems to be rising because of the current epidemic of obesity 3 .
Women of any ethnic background can present with PCOS. 4% to 4.7% of white women and 3.4% of African American women had PCOS 4 .
The aetiology of PCO is uncertain. There is some evidence of autosomal transmission related to strong familiar clustering. It also represents a complex trait in which a small number of major genes interact with environmental and other genetic factor to account for the heterogeneity 5 .
Family study has revealed that about 50% of first degree relatives have PCOS suggesting a dominant mode of inheritance 6 .
Although USG finding of PCO present in women but of them 66% notice abnormal menstrual pattern 7 . The menstrual cycle abnormality ranges from amenorrhoea, oligomenorrhoea to menorrhagia. Patient with PCOS may experience endometrial hyperplasia. About 15% to 30% of women with PCOS may have regular cycle in spite of anovulation 4 .
Infertility is a common problem in women with PCOS. The syndrome accounts for 90-95% of women who attend infertility clinics 8 . The chance of pregnancy with PCOS women using fertility treatment is very good 9 .
The prevalence of obesity is high in patient with PCOS. The rate of obesity in PCOS population ranges from 38% to 87%. The cause of obesity in PCOS is not fully known. The obesity of PCOS is of the android type (central type). There is an increased waist to hip ratio associated with hyperandrogenemia, insulin resistance, glucose intolerance and dyslipidemia 10 .
Excessive hair growth is the most distinction and visible feature of PCOS. The hair growth usually are seen on the face, upper lip, chin and lower abdomen as an extension of pubic hair towards the umbilicus. Women with PCOS may experience increase skin oiliness secondary to excessive stimulation of the pilosebaceous unit. Acanthosis nigricans appears as symmetrical darkness that appears commonly on the nape of the neck 11 .
PCOS are most often diagnosed by means of laboratory studies. The ratio of the LH to the FSH level is useful in the diagnosis. The ratio of LH to FSH is greater than 1:1, as tested on day 3 of the menstrual cycle. This change in LH to FSH ratio is enough to disrupt ovulation 12 .
Serum level of androgens including androstenedione, testosterone and dehydro-epiandrosterone sulfate may be elevated. The free testosterone level is thought to be the best means 13 . Total testosterone ranges are 6-86 ng/ dl. Free testosterone refers to the amount of testosterone that is unbound and actually active and its ranges from 0.7-3.6 ng/dl. Women with PCOS often have an increased level of both total testosterone and free testosterone 12 .
According to the Rotterdam criteria the ultrasonic feature of PCO are defined and include either 12 or more follicles, measuring 2-9 mm in diameter and increased ovarian volume >10cm 3 . It is essential that the ultrasound scans is performed at a time of ovaries quiescence such as during the early follicular phase of the menstrual cycle 14 . Measurement of LH, FSH and Testosterone Level: 5ml venous blood was collected from each subject with all aseptic precaution using sterile disposable plastic syringe by anticubital venipuncture and poured into a clean glass test tube. The collected blood was allowed to clot at room temperature. Serum was separated and taken in other three plastic test tube. Each test tube is leveled separately for LH, FSH and testosterone. Antibody of LH, FSH and testosterone were added to these serum and mixed well. Then these test tube are kept for 2 hours at 37 0 C temperature. After that I 125 were added to these test tube and incubated at 4 0 -7 0 C temperature. Duration of incubation time was different for each hormone. After that incubation time the serum was kept in room temperature for 30 minutes. Then 500 microliter precipitating solution was added in each test tube and mixed well. These test tube were kept in centrifuge machine and centrifuge it at 3500 Rpm. Precipitant were appeared at the bottom test tube. The level of these hormones were measured from these Precipitant.
Meterial and Methods
Transabdominal ultrasonography was performed with 3.5MHz curvilinear electronic probe in the Center for Nuclear Medicine and Ultrasonography (CNMU), MMCH to all the women of this study in full bladder. The diagnosis of PCO was done by ovarian volume (e"10 cm 3 ), stromal echotexture and follicular number (>10).
Data were collected using a structured questionnaire containing all the variables of interest. Collected data were processed and analyzed using computer based software SPSS (Statistical Package for Social Sciences) version 12. A probability value of<0.05 was considered significant. The summarized data were presented in the form of tables and graphs with due interpretation.
Results:
Fifty five (55) women with PCO were selected from outdoor department of Obs and Gynae MMCH having USG report from Centre for Nuclear Medicine and Ultrasonography MMCH during the period of December 2009 to November 2010. All cases were evaluated clinically (age, BMI, hirsutism, menstrual cycle pattern and fertility status). Hormonal level (LH/ FSH ratio and total testosterone level) were done for all cases.
The findings and related interpretation are presented in tables and figures according to the objectives of the study. 
Fig-1: The testosterone level & LH/ FSH ratio of the respondents.

Table-VII
Relationship between BMI, hirsutism and fertility status with levels of testosterone (N=55).
Clinical Characteristics Testosterone (n %) 
Discussion:
Polycystic ovaries are seen by USG finding in 20-25% women of reproductive age. PCOS occur in at least 5% women of the population. Polycystic ovaries can be diagnosed in patient of any age from menarche. Typically women in their 20s present with polycystic ovary syndrome 15 . In present study among 55 women, 72.7% were within the age of 20-29 years. The mean age was 23.55 years. In another study, the mean ± SD of age distribution was 21.9 ± 3.06 16 , which is nearer to present study. A recent study showed that the common age of PCO women were 21-25 years 17 . This result is also close to the present study.
In the present study, thirty eight out of the fifty five women were overweight and obese with mean BMI of 27.12±3.52 kg/m 2 . In another study mean BMI was 27.1kg/m 2 17 . Mean BMI of PCO women were 28.98 kg/m 2 in an Indian study 16 . Both the results are nearer to present study.
In the present study hirsutism was present in 36.4% cases. In a study at BSMMU 50% women had hirsutism 17 . The percentage was more than the present study because asymptomatic women with PCO were included. The presence of hirsutism was significant among women with PCO than without PCO in an Indian study 18 .
The common presentation of the women having PCO was menstrual disturbance 7 . In the present study out of 55 women, 35 (63.6%) women attended in outdoor department with irregular menstrual cycle.
Among them 56.3% women had oligomenorrhoea. The study at BSMMU showed that women with PCOS had oligomenorrhoea in 28% cases 17 . The percentage was less than the present study. In a study in Iraq, oligomenorrhoea was prevalent in 43.93% women, nearer to the present study 19 .
56.3% women with PCO attended in outdoor department due to subfertility (both primary and secondary) during the study time period. Among them about 28 (50.8%) women had primary subfertility and 3(5.5%) women had secondary subfertility. In the study of BSMMU, primary subfertility was found in 90% cases and secondary subfertility was found in 10% cases 17 .
According to a literature, 16-25% of normal ovulatory women have polycystic ovaries without evidence of the syndrome, a subgroup of women with PCO (up to 30%) may have PCOS 1 . In present study out of 55 women, 60% women had PCOS and 40% women had only PCO, not similar to the literature review.
In the present study, 58.2% women with PCO had LH/ FSH ratio more than 1:1. Increased testosterone level was found in 58% women with PCO. In an Indian study, 55.55% women had increased LH/FSH ratio and 64.44% women had increased testosterone level which is closed to present study 16 . 53.8% women with oligomenorrhoea and 3.7% women with amenorrhoea had increase testosterone level in present study. The result is significant. In another study 73% girl with irregular menstrual cycle (oligomenorrhoea and amenorrhoea) had the highest androgen level, nearer to present study 17 .
In the present study 49% cases with increased testosterone level were over weight and obese (BMI>25kg/m 2 ) and 20% cases with normal testosterone level were overweight and obese. The result is significant. Increased testosterone levels among overweight and obese women were found in 59.18% cases in another study 16 . The result of the present study is nearer to this study.
In the present study hirsutism was present in 36.4% cases. In relation with hirsutism and testosterone level, 29% women with increase testosterone level had hirsutism whereas 7% women with normal testosterone level had hirsutism. The result is significant. In an Indian study, 44.2% women with hirsutism had significantly high testosterone level 16 . The result is more than the present study.
In the present study 27.5% women with primary subfertility and 1.8% women with secondary subfertility had increased testosterone level. The result is not significant. Other study showed 36% subfertile women with PCO and 28% subfertile women without PCO had increased testosterone level 21 . So their result supports present study.
In the relation between menstrual cycle pattern and LH/ FSH ratio, 46.4% women with oligomenorrhoea and 3.6% women with amenorrhoea had increase LH/FSH ratio in present study and 11.1% women with oligomenorrhoea and 1.8% women with amenorrhoea had LH/FSH ratio at or less than 1:1. The result is significant. Study in Iraq about correlation between LH/ FSH ratio and disease menifestation showed no significant correlation between menstrual cycle pattern and LH/FSH ratio 20 .
In present study 43.6% obese and overweight women had > 1:1 LH/FSH ratio. On the other hand 25.5% obese and overweight women had at or less than 1:1 LH/FSH ratio. The result is not significant. In a study in Iraq, they also found that there was no significant correlation between BMI and LH/FSH ratio 20 . This result has similarity to present result.
About the correlation between hirsutism and LH/FSH ratio, 27% women with hirsutism had increased LH/ FSH ratio and 9% women with hirsutism had LH/FSH ratio at or below 1:1. The result is not significant. Statistical correlation between LH/FSH ratio and hirsutism was not significant in a study in Iraq 20 .
In the present study, 29.2% women with primary subfertility and 1.8% women with secondary subfertility had LH/FSH ratio more than 1:1. Whereas 22% women with primary subfertility and 3.6% women with secondary subfertility had LH/FSH ratio at or less than 1:1. The result was not significant. Another study had increased LH/FSH ratio in 60% subfertile women with PCO and 70% women without PCO 21 . So their result supports the present study.
The required size was not possible to collect because of limitation of time and financial constrains. All the facts and figures mentioned here may considerably vary from those of large series covering wide range of time.
Conclusion:
Irregular menstruation, increased BMI, hirsutism and subfertility are the common presentation of women with PCOS. There are significant relationship between irregular menstrual cycle pattern and hormonal changes such as testosterone level and LH/FSH ratio. There are also significant relationship between BMI and hirsutism with increased testosterone level. Common future outcome of PCOS are type 2 diabetes mellitus, hypertension, cardiovascular disease and endometrial carcinoma. Early diagnosis and proper preventive management of these patients with PCO will reduce reproductive and non reproductive morbidity.
